Cinnarizine/dimenhydrinate

Cinnarizine/dimenhydrinate

Combination of
Cinnarizine	Antihistamine and calcium channel blocker
Dimenhydrinate	Antihistamine and antiemetic
Clinical data
Trade names	Cizigo, Cizinate, Cizere
Pregnancy category	AU: B2
Routes of administration	By mouth
ATC code	N07CA52 (WHO)
Legal status
Legal status	AU: S4 (Prescription only)
Identifiers
CAS Number	298-57-7 523-87-5
UNII	3DI2E1X18L JB937PER5C

Cinnarizine/dimenhydrinate, sold under the brand name Cizinate among others is a fixed-dose combination medication for the treatment of vertigo in adults. It contains cinnarizine and dimenhydrinate. It is taken by mouth.

It was approved for medical use in Australia in December 2018.

Further reading

• Hahn A, Novotný M, Shotekov PM, Cirek Z, Bognar-Steinberg I, Baumann W (2011). "Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study". Clin Drug Investig. 31 (6): 371–83. doi:10.2165/11588920-000000000-00000. PMID 21401214. S2CID 26720922.
• Scholtz AW, Ilgner J, Loader B, Pritschow BW, Weisshaar G (May 2016). "Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice". Wien. Klin. Wochenschr. 128 (9–10): 341–7. doi:10.1007/s00508-015-0905-5. PMC 4875047. PMID 26659910.
• Scholtz AW, Schwarz M, Baumann W, Kleinfeldt D, Scholtz HJ (June 2004). "Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study". Clin Ther. 26 (6): 866–77. doi:10.1016/s0149-2918(04)90130-0. PMID 15262457.

External links

• "Cinnarizine". Drug Information Portal. U.S. National Library of Medicine.
• "Dimenhydrinate". Drug Information Portal. U.S. National Library of Medicine.